Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma

Affiliations

• ¹ Department of Medicine, UT Southwestern Medical Center, Blood and Marrow Transplant Program, Dallas, TX.
• ² Division of Hematology, Mayo Clinic, Rochester, MN.
• ³ Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI.
• ⁴ Department of Medicine, Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, WI.
• ⁵ Department of Medicine, Standford University School of Medicine, Stanford, CA.
• ⁶ Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, FL.
• ⁷ Division of Hematology-Oncology; University of California San Francisco, San Francisco, CA.
• ⁸ Department of Medicine, Ohio State Medical Center, James Cancer Center, Columbus, OH.
• ⁹ Division of Hematology/Oncology, Bone Marrow Transplantation and Cellular Therapy, Medical College of Wisconsin, Milwaukee, WI.
• ¹⁰ Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland, OH.
• ¹¹ Bone Marrow Transplant Service, Division of Hematology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.
• ¹² Royal Adelaide Hospital, Adelaide, SA, Australia.
• ¹³ Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.
• ¹⁴ Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, IL.
• ¹⁵ Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
• ¹⁶ Mayo Clinic, Rochester, NY; and.
• ¹⁷ MD Anderson Cancer Center, Houston, TX.